XLV:ARCA-SPDR Select Sector Fund - Health Care (USD)

ETF | Health | NYSE Arca

Last Closing

USD 146.2

Change

+2.14 (+1.49)%

Market Cap

USD 13.53B

Volume

8.43M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Inception Date: 16/12/1998

Primary Benchmark: S&P Health Care Select Sector TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.15%

Management Expense Ratio: 0.13 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
FHLC Fidelity® MSCI Health Care In.. 0.08 %

-0.13 (-0.18%)

USD 2.86B
FXH First Trust Health Care AlphaD.. 0.63 %

+0.33 (+0.31%)

USD 1.18B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

+0.24 (+0.27%)

USD 0.21B
IDNA iShares Genomics Immunology an.. 0.00 %

+0.08 (+0.32%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF 0.50 %

-0.53 (-1.37%)

USD 0.12B
XHS SPDR® S&P Health Care Service.. 0.35 %

-1.28 (-1.35%)

USD 0.08B
HTEC Robo Global® Healthcare Techn.. 0.00 %

+0.12 (+0.43%)

USD 0.05B
BBP Virtus LifeSci Biotech Product.. 0.79 %

-0.56 (-0.87%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

-0.55 (-1.87%)

USD 0.01B
IHE iShares U.S. Pharmaceuticals E.. 0.42 %

-0.73 (-1.04%)

N/A

ETFs Containing XLV

HYLG Global X Funds - Global X.. 53.23 % 0.00 %

-0.05 (0.15%)

N/A
CLSM Cabana Target Leading Sec.. 30.09 % 0.00 %

-0.12 (0.15%)

USD 0.16B
TDSC Cabana Target Drawdown 10.. 15.22 % 0.00 %

-0.04 (0.15%)

USD 0.21B
TACK Fairlead Tactical Sector .. 11.81 % 0.00 %

-0.04 (0.15%)

USD 0.22B
SSUS Day Hagan/Ned Davis Resea.. 10.72 % 0.00 %

-0.22 (0.15%)

USD 0.61B
THLV THOR Financial Technologi.. 9.80 % 0.00 %

-0.03 (0.15%)

USD 0.08B
AESR 9.73 % 0.00 %

N/A

N/A
PSTR PeakShares Sector Rotatio.. 9.45 % 0.00 %

+0.04 (+0.15%)

USD 0.01B
QPX AdvisorShares Q Dynamic G.. 6.02 % 0.00 %

-0.23 (0.15%)

USD 0.03B
TDSB Cabana Target Drawdown 7 .. 4.89 % 0.00 %

-0.02 (0.15%)

USD 0.09B
HAC:CA Global X Seasonal Rotatio.. 4.39 % 1.27 %

-0.14 (0.15%)

CAD 0.22B
LCR Leuthold Core ETF 4.20 % 0.00 %

-0.06 (0.15%)

USD 0.09B
EQL ALPS Equal Sector Weight .. 0.00 % 0.15 %

-0.08 (0.15%)

N/A
FUT:CA 0.00 % 0.81 %

N/A

N/A
QGTA 0.00 % 0.37 %

N/A

N/A
QLS 0.00 % 0.76 %

N/A

N/A
EQL ALPS Equal Sector Weight .. 0.00 % 0.26 %

-0.08 (0.15%)

N/A
EQL ALPS Equal Sector Weight .. 0.00 % 0.26 %

-0.08 (0.15%)

N/A
XLSR SPDR® SSGA U.S. Sector R.. 0.00 % 0.00 %

-0.20 (0.15%)

USD 0.62B
USHG 0.00 % 0.00 %

N/A

N/A
FATT 0.00 % 0.00 %

N/A

N/A
RSPY 0.00 % 0.00 %

N/A

N/A
RRH 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.20% 81% B- 62% D
Dividend Return 0.38% 83% B 21% F
Total Return 7.58% 86% B+ 59% D-
Trailing 12 Months  
Capital Gain 11.59% 90% A- 54% F
Dividend Return 1.68% 100% F 24% F
Total Return 13.27% 90% A- 49% F
Trailing 5 Years  
Capital Gain 65.31% 100% F 75% C
Dividend Return 8.53% 94% A 30% F
Total Return 73.84% 100% F 75% C
Average Annual (5 Year Horizon)  
Capital Gain 9.86% 90% A- 70% C-
Dividend Return 11.08% 100% F 67% D+
Total Return 1.21% 89% A- 29% F
Risk Return Profile  
Volatility (Standard Deviation) 10.73% 90% A- 80% B-
Risk Adjusted Return 103.27% 100% F 98% N/A
Market Capitalization 13.53B 100% F 94% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike